GlassScriptPhysician profile
Herman L Rundle
NPI 1942242326
$2,906.63
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $985 · 2020: $490 · 2021: $610 · 2022: $311 · 2023: $265 · 2024: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $510.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $836.15 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $410.35 | 2019-2021 | |
| Alcon Vision LLC | $290.54 | 2020-2024 | Rocklatan |
| New World Medical,INC. | $283.13 | 2019 | |
| Horizon Therapeutics Plc | $173.22 | 2021-2023 | Tepezza |
| Genentech USA, INC. | $149.04 | 2022 | |
| Glaukos Corporation | $144.86 | 2019-2023 | |
| Abbvie INC. | $131.45 | 2022-2024 | Durysta |
| Dompe US, INC. | $125.00 | 2021 | |
| Astellas Pharma US INC | $64.18 | 2024 | Izervay |
| Oyster Point Pharma, INC. | $60.82 | 2023-2024 | Tyrvaya |
| Rxsight INC | $43.74 | 2022-2023 | Rxsight Injector Cartridge, Rxsight Injector Handpiece, Rxsight Contact Lens |
| Novartis Pharmaceuticals Corporation | $43.50 | 2020-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $37.12 | 2022-2023 | Tecnis Iol |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $34.68 | 2020-2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $33.21 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $16.23 | 2022 | |
| Beaver-Visitec International, INC. | $15.50 | 2021 | |
| Bausch & Lomb Americas INC. | $13.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herman Rundle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.